chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever; Nauseous; Headache; broke out with pimples; Lethargic; she got really sick after the second dose; Rash; struggled to breath; This is a spontaneous report from a contactable 53 year-old female consumer (patient) communicated to a Pfizer colleague that reported a 53-year old female received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: FF8841), via an unspecified route of administration on 29Sep2021 (at the age of 52 years old) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. Historical vaccine included first dose of BNT162B2 (Lot Number: FC3183) on 08Sep2021 (at the age of 52 years old) for covid-19 immunisation. Reporter a Pfizer employee reporting for his cousin regarding the Pfizer Covid vaccine and who explained that she received both doses. It was reported that with first shot, it was no big deal. It was explained she got really sick after the second dose. Twelve hours after the second dose she developed a rash that looked like ring worms or cigarette burns. It was all over her body but mainly on the arm she received the injection, caller thinks it was the left arm. After that when she went to lay down to sleep, she reported she struggled to breath on 29Sep2021. It felt like someone was crushing her chest. This lasted about 24 hours, the trouble breathing. She also got a fever, was nauseous and had a headache. Her head felt so heavy she couldn't not lift off her pillow. Also, she felt super lethargic, so much so she couldn't get up out of bed. In response to the breathing, she relayed she literally could not breath and this was the first time that had ever happened to her. It was absolutely horrible. She stated she will not get a booster shot. Also it was explained she broke out with pimples. The reporter's sister came over and gave her something and within 30 minutes she was feeling better. It was some herbal treatments, pine needle tea and charcoal to drink. Her sister also made her a drink of zinc mixed with lemon and grapefruit skin. Within 30 minutes of taking all this she started to feel better. It was stated that after taking all this and is getting better, she is able to pull the little blisters off her skin. No testing done. The outcome of struggled to breath was recovered on 30Sep2021, while with other events was unknown.  Follow-Up (13Oct2021): Follow-up attempts are completed. No further information is expected.
On 05/12/2022 Test positive at 11:00PM . My throat was sore; Coughing; Excessive drainage back of my throat. On 05/14/2022  I did a tele health  with my doctor. He prescribed me Paxlovid for 5 days.  Within 48hours of the medication I felt great. It worked very well.
This case was reported by a consumer via call center representative and described the occurrence of joint pain in a 68-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (On 22nd June 2018, received 1st dose intramuscularly in left arm). On 15th January 2019, the patient received SHINGRIX (intramuscular) .5 ml. In January 2019, less than a week after receiving SHINGRIX, the patient experienced joint pain and muscle pain. On 15th January 2019, the patient experienced drug dose administration interval too long. The patient was treated with prednisone. On an unknown date, the outcome of the joint pain, muscle pain and drug dose administration interval too long were unknown. It was unknown if the reporter considered the joint pain and muscle pain to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient's husband. The patient received 2nd dose late than recommended time frame, which led to lengthening of vaccination schedule. She experienced muscle pain and joint pain with the second dose of the vaccine. She stated that it felt like her muscles were on fire. On 17th January 2019, she saw her physician assistant due to the pain she was experiencing. She was then prescribed Prednisone to be taken for 5 days. The patient also wanted to know how effective the vaccine would be since she received the second dose after the recommended time frame. Consent to follow up was given. No further details were provided. Referred the patient to the healthcare professional and provided phone number to medical information for the healthcare professional to call.
Headache, fever, cough, body aches, tachycardia 130, drop in O2 sat to 89 once
12 hours after receiving the Pfizer-BioNTech COVID-19 Vaccine EUA, the patient experienced heart pounding and palpitations. Went back to sleep and in the morning (~11am) his heart rate was 120-135 bpm at rest. On rising it elevated to 153. The advice nurse advised us to go to the ER 8/14. Blood work in the ER was negative for troponins and chest x-ray negative (myocarditis appeared to be ruled out), but tachycardia persisted after receiving 2 L IVF and he was discharged as such. Symptoms worsened over the next 3 days and a virtual MD visit advised us to return to the ER on 8/16. His heart rate would elevate 30-40 bpm on rising and would be mildly tachycardic while at rest. Despite 3 L IVF in the ER, he was very orthostatic. He was discharged home still with tachycardia which is only relieved by laying flat. He is currently wearing a heart monitor provided by a cardiologist following the ER visit and is being worked up for postural orthostatic tachycardia syndrome secondary to the first vaccine. It has been 11 days and the symptoms have not improved. Heart rate elevates to 145-151 on standing. Dizziness and head pressure when sitting.  This vaccine has completely altered his health, which was perfect prior to receiving this initial dose.
Sharp pain in my back, middle of my back; felt like there was a knife injected on it; A spontaneous report was received from a Consumer concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sharp pain in my back, middle of my back, felt like there was a knife injected on it.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 24 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Not available) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 25 Feb 2021, the patient experienced the events sharp pain in my back. middle of my back, felt like there was a knife injected on it.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.  On an unknown date the outcome of events, sharp pain in my back, On an unknown date the outcome of events, middle of my back, On an unknown date the outcome of events, felt like there was a knife injected on it was not reported.
Pulmonary embolism; This is a spontaneous report received from a contactable reporter(s) (Physician).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PULMONARY EMBOLISM (medically significant), outcome "unknown".   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information provided, a causal relationship between BNT162B2 and the reported event Pulmonary embolism cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Felt like was fainting; Five to ten minutes after receiving the first dose I started feeling dizzy; numb (tingling) in my fingers.; numb (tingling) in my fingers.; I also started to sweat; my BP fell when the nurse checked.; This is a spontaneous report from a contactable consumer (patient). A 33-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in Arm Left on 06Apr2021 12:45 (Lot Number: ER8737) as single dose for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported. There was no other vaccine in four weeks or in two weeks.  There was no known allergies. The patient has no Covid prior vaccination and has no Covid tested post vaccination. After receiving the first dose, on 06Apr2021 13:00, the patient started feeling dizzy and numb (tingling) in his fingers. Felt like him was fainting. He also started to sweat and his BP fell when the nurse checked. The patient did not have a full breakfast or lunch before getting the dose. The patient had coffee in the morning with some dates and later had two oranges and a Kind Nut Bar. Drank some water and juice after the dizziness subsided. The events did not result in emergency room visit or physician office visit. Therapeutic measures were taken as a result of all the events. The outcome of events was resolved on unknown date.
Got TDAP 9-21-10 Rt arm - now arm swollen & warm to touch - used cold compresses on arm have not seen doctor I just had a baby a week ago.
At 90 min post vaccine with weakness, dizziness, fever and chills. At 27 hours with generalized urticaria moderate to severe over ex tensor surfaces of all joints.
Joint pain- especially in wrists, fingers, ankles, and toes, but elsewhere in body as well- lasted until August 27th Dizzy feeling started on the 13th. Turned into vertigo 5 days after receiving the vaccine- around August 17th. Still have vertigo that comes and goes throughout each day (Today is the 27th of August and it has not subsided).
feel pain in my arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (feel pain in my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced MYALGIA (feel pain in my arm). At the time of the report, MYALGIA (feel pain in my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant Medications were reported. Treatment Information was not provided by the reporter.
Rash 5+ Pain on site of vaccine itching  Unable to raise arm Fatigue  Tiredness  Difficulties breathing  Thirsty  Confuse  Low energy
The patient needed 1200 units (8ml) of HRIG administered around the would cat bit wound after the surgeon had completed the washout due to a cellulitis caused by the cat bit. All 8ml were injected into the right wrist/lower right arm area around the wound. The patient was complaining of numbness in the thumb and extreme pain 10/10 that was not relived with narcotic use.
Arthritis in left hip. Will not go away. Constant pain (though only about 2 on scale of 1-10). Started with unusual pain in hip. Confirmed with x-ray. On meloxicam for pain when needed.
Her absent seizures started again after the second moderna shot on 10 April. She developed slight fever the next day and by 12 April Monday she started having the seizures and feeling weak and tired. She?s been feeling like that ever since. We went to the ER today, she?s still having random seizures but everyday she?s feeling tired and weak, today she had pressure on the back of the head and blurry vision.
Reaction right away after first primary dose/Reaction right away after 2nd primary dose; Fever right  after first primary dose/Fever right  after 2nd primary dose; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (Reaction right away after first primary dose/Reaction right away after 2nd primary dose) and PYREXIA (Fever right  after first primary dose/Fever right  after 2nd primary dose) in an adult female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Reaction right away after first primary dose/Reaction right away after 2nd primary dose) and PYREXIA (Fever right  after first primary dose/Fever right  after 2nd primary dose). At the time of the report, IMMUNISATION REACTION (Reaction right away after first primary dose/Reaction right away after 2nd primary dose) and PYREXIA (Fever right  after first primary dose/Fever right  after 2nd primary dose) outcome was unknown.            It was reported that the patient was over 18 years of age. Patient received First and Second Monovalent Booster doses from Moderna Vaccine. No concomitant medications were reported. No treatment details were reported. Patient had no reactions after 1st and 2nd Booster doses.   Reporter did not allow further contact
Headache; Allergy type feeling in chest; Diarrhea; This is a spontaneous report from a contactable consumer (Patient) via Pfizer sponsored program. A male patient of an unspecified age received first dose of bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 30Apr2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient has had a headache and felt like he had an allergy type feeling in chest. The patient had a mild headache and a little reaction, some type of reaction in his chest, but it had disappeared, but by Monday he had diarrhea and it had not stopped. It went away and now (at the time of report) had diarrhea for 8 days. The patient wanted to know how long it will last. Did read it as one of the side effects, but he has had no history of that kind of problem. Wants to know what is suggested for this side effect with the diarrhea, how long it will last. Investigation assessment was not provided. On an unknown date in 2021, the patient recovered from events headache and allergy type feeling in chest and the clinical outcome of diarrhea was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
pt recvd MMR vax 17JAN92 & w/in 5 mins pt fainted; heart rate was between 30 to 50 & BP 90/50; MD noted pt looked pale; dx syncope, probable vasovagal rxn;
Two hours after receiving the immunization, patient experienced some soreness, redness and swelling in her left arm. Shee thought that it was normal. She woke up the next morning and it was still sore, big and swollen from her shoulder to elbow and the redness was spreading under her arm to her chest. She took extra strength Tylenol which helped and also some Benadryl. She woke up today, 11/17 and the redness is still there but the itching, swelling and soreness is better.
Stasis dermatitis/dermatitis got worse after taking the Pfizer COVID-19 shots.; I experienced insomnia for about three nights after taking the COVID-19 Pfizer vaccine.  I continue to have insomnia from time to time.; This is a spontaneous report from a contactable consumer, reported for himself. A 75-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205), dose 2 via an unspecified route of administration on right arm on 27Feb2021 13:00 as a single dose for covid-19 immunization. Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 1 via an unspecified route of administration on left arm on 06Feb2021 13:00 as a single dose for covid-19 immunization. Medical history included spinal stenosis, hypertension, stasis dermatitis. Concomitant medication(s) and received within 2 weeks of vaccination included hydrochlorothiazide, losartan potassium (LOSARTAN/HCTZ). The patient had no other vaccine within four weeks and other medications received within 2 weeks of vaccination- allergy shot- on 19Feb2021, Pulmonary Associates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had known allergies with ciprofloxacin, prednisone. On 28Feb2021 12:00, the patient experienced insomnia for about three nights after taking the covid-19 pfizer vaccine and continue to have insomnia from time to time. For this event he did not received any treatment. On 31Mar2021 12:00, he was being treated for stasis dermatitis at the Dermatology Center. It seems the dermatitis got worse after taking the Pfizer COVID-19 shots and a steroid shot was administered as treatment. Outcome of the event insomnia was resolving and other was not resolved. Follow-up attempts are possible. Further information is expected.
No adverse event; Patient given expired dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient given expired dose) and NO ADVERSE EVENT (No adverse event) in a 63-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 010H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2023, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. In 2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient given expired dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient given expired dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient given expired dose).    No concomitant medications were reported. It was unknown if the patient experienced any additional symptoms/events.  No treatment medications were reported.
Pain at injection site pain never went away on 12/18/18 tingling started left hand fingers.
Per doctor, patient had localized reaction (1/2 of upper arm red and swollen) to dtap, doctor stated she cleaned wound and reassured patient/parent.
Pfizer-BioNTech COVID-19 Vaccine EUA  Injection given at 1420.  He was watched for 15 minutes following vaccine administration without incident.  Returned endorsing dizziness and nausea at 1455.  Was tachycardic with HR in 130s with elevated BP with systolic in 150s.  Given hydration and vitals monitored for about 45-55 minutes.  Vitals downtrended and began to normalize.  Stood to leave and became diaphoretic and weak.  Placed in wheelchair for transfer down the hall to the ER and became unresponsive on the way.  Was given epinephrine 0.3 mg to L thigh.  Given IV fluids and acetaminophen.  Returned to usual state of health and was discharged home.
pt recvd vax 27FEB96 430PM & mom called MD last noc pt had cont crying for 3-4hrs;no fever;RT bruised, swollen;mom gave APAP & motrin & to call in AM w/progress
Patient slumped forward from chair following receiving his vaccine. Regained consciousness within 5-10 seconds and was awake and oriented. 911 was called and paramedics came and began caring for the patient. They took him to the hospital and reported to me that his blood pressure and heart rate were both low. His family reported that he has a fear of blood and needles and it seems the event was triggered more by anxiety to the shot itself rather than the actual vaccine.
Living in an assisted living facility. She was basically forced in to having Covid Vaccine. She was ill after first dose. Second dose, severe reaction, resulting in stroke, within 48 hours. Spent the next few months in a nursing home, unable to walk or talk, short term memory has really suffered as well. Her walking especially her left side/leg, has not recovered, she has worked so hard to get function back too. Complete nightmare, especially at her age.  Now, she is forced to wear a mask at all times, because she has not been boosted. The boosting has not worked, they have constant outbreaks of Covid in her facility, and yes, these are fully vaxed and boosted residents. I refuse to get her another experimental and deadly Covid vaccine, it is not worth the risk of another reaction, that will be too much on her. Especially, since they don't stop it.
no adverse event; he took his 1st Moderna shot on 27-Oct-2022, no 2nd dose yet after the 1st dose (more than 36 days); This spontaneous case was reported by a patient and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (he took his 1st Moderna shot on 27-Oct-2022, no 2nd dose yet after the 1st dose (more than 36 days)) and NO ADVERSE EVENT (no adverse event) in a male patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Oct-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 27-Oct-2022, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (he took his 1st Moderna shot on 27-Oct-2022, no 2nd dose yet after the 1st dose (more than 36 days)). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (he took his 1st Moderna shot on 27-Oct-2022, no 2nd dose yet after the 1st dose (more than 36 days)) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTRATION INTERRUPTED (he took his 1st Moderna shot on 27-Oct-2022, no 2nd dose yet after the 1st dose (more than 36 days)).    No concomitant medications was reported. No treatment drug details was reported.   Reporter did not allow further contact
Vomiting x1. Fever 101 degrees Fahrenheit for 24 hours, inflammation, redness, at injection site for 48 hours.
This spontaneous report as received from a vaccine coordinator refers to a patient of unknown age and gender. No medical history and concurrent condition were reported. On 11-JAN-2019, the patient was vaccinated with an improperly stored second dose of PROQUAD (lot # R020677, expiry date 15-JAN-2020) for prophylaxis. The suspect vaccine was reconstituted with an properly stored sterile diluent. The vaccine was exposed to the temperature of -14.6 degree Celsius (C) for 30 minutes. Previous excursion included exposure to 0.1 C for 2 hours and -13.7 C for 45 minutes. A data logger was involved. No adverse effects were reported. No product quality complaint was present. This is one of the several reports received from same reporter source. Sender's Comments: US-009507513-1901USA006017.